FOXE1 and thyroid gland carcinoma: Relative to GWAS, the coverage of selected gene regions was higher, although we could have missed important associations with SNPs in gene regions not included within the genotyping platform such as in FOXE1. While among the larger studies in the field with respect to the number of thyroid cancer cases and controls, our study had limited power (<80%) to detect modest-to-weak associations (OR <1.7) especially for less common genetic variants (MAF ≤10%).